Sign inJoin waitlistJoin the waitlist

Mark Mirochnick

Section Director · Boston University Medical Center

Credentials: · ·

History

Boston University Medical Center
Present
Boston University Medical Center
Present

Neonatal-Perinatal Medicine
University of Connecticut School of Medicine
1984–1986
Pediatrics
Boston Children's Hospital
1980–1983
The Robert Larner, M.D. College of Medicine at the University of Vermont
1976–1980

Research

Intrapartum and neonatal single-dose nevirapine compared with zidovudine for prevention of mother-to-child transmission of HIV-1 in Kampala, Uganda: HIVNET 012 randomised trial
The Lancet · 1999 · 1,263 citations
Intrapartum and neonatal single-dose nevirapine compared with zidovudine for prevention of mother-to-child transmission of HIV-1 in Kampala, Uganda: 18-month follow-up of the…
The Lancet · 2003 · 367 citations
Selection and fading of resistance mutations in women and infants receiving nevirapine to prevent HIV-1 vertical transmission (HIVNET 012)
AIDS · 2001 · 320 citations

Edmund Capparelli
73 papers
Alice Stek
46 papers
LM
Lynne Mofenson
32 papers
Ahizechukwu Eke
22 papers · 4 as a fellow
SB
Sandra Burchett
22 papers
NC
Nahida Chakhtoura
20 papers
Yvonne Bryson
15 papers
Stephen Spector
12 papers
JR
Jennifer Read
11 papers
Mary Fowler
9 papers
Sharon Nachman
8 papers
BZ
Barry Zuckerman
7 papers

Grants

Antiretroviral Pharmacology/Lactating Mother/Infants
National Institute of Child Health and Human Development · R21
Contact PI · $453.5K · Boston Medical Center
2005–2009
Safety Pharmacokinetics & Efficacy of Artemether & Lumefantrine in Pregnant Women
National Institute of Allergy and Infectious Diseases · R34
Contact PI · $123.2K · Boston Medical Center
2008–2009
General Clinical Research Center
National Center for Research Resources · M01
Project lead · $307.2K · Boston University Medical Campus
1997–2007
Mass Spectrometry Resource for Biology and Medicine
National Center for Research Resources · P41
Project lead · Boston University Medical Campus
1998–1999

Clinical trials

Pharmacokinetic Properties of Antiretroviral and Anti-Tuberculosis Drugs During Pregnancy and Postpartum
Study chair · Terminated
National Institute of Allergy and Infectious Diseases (NIAID)
2021–2025
PK and Safety of Remdesivir for Treatment of COVID-19 in Pregnant and Non-Pregnant Women in the US
Study chair · Completed
National Institute of Allergy and Infectious Diseases (NIAID)
2021–2022
Evaluating the Safety and Pharmacokinetics of Maraviroc in HIV-1-Exposed Infants at Risk of Acquiring HIV-1 Infection
Study chair · Completed · Phase 1
National Institute of Allergy and Infectious Diseases (NIAID)
2017–2019
IMPAACT P1106: Pharmacokinetic Characteristics of Antiretrovirals and Tuberculosis Medicines in Low Birth Weight Infants
Study chair · Completed
International Maternal Pediatric Adolescent AIDS Clinical Trials Group
2015–2020